NCT00637780View on ClinicalTrials.gov

Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis

PHASE4TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Arthritis, Juvenile Rheumatoid

Interventions

DRUG

Sulfasalazine

Sulfasalazine delayed release tablets 30-60 mg/kg/day (divided into BID doses) for 7 days. Blood sampling for Pharmacokinetic assessment to be performed on Day 7

Trial Locations (2)

44106

University Hospitals Case Medical Center, Cleveland

44650

Private Office, Guadalajara